Your browser doesn't support javascript.
loading
First-line endocrine therapy for advanced breast cancer. A real-world study at a Latin American university health institution.
Walbaum, Benjamin; Acevedo, Francisco; Medina, Lidia; Bravo, M Loreto; Merino, Tomas; Camus, Mauricio; Dominguez, Francisco; Mondaca, Sebastian; Galindo, Hector; Nervi, Bruno; Ibañez, Carolina; Madrid, Jorge; Peña, Jose; Koch, Erica; Garrido, Marcelo; Pinto, Mauricio P; Sánchez, César.
Afiliación
  • Walbaum B; Department of Hematology-Oncology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Acevedo F; Department of Hematology-Oncology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Medina L; Centro de cáncer Red Red de Salud UC Christus, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Bravo ML; Department of Hematology-Oncology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Merino T; Department of Hematology-Oncology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Camus M; Department of Surgical Oncology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Dominguez F; Department of Surgical Oncology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Mondaca S; Department of Hematology-Oncology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Galindo H; Department of Hematology-Oncology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Nervi B; Department of Hematology-Oncology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Ibañez C; Department of Hematology-Oncology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Madrid J; Department of Hematology-Oncology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Peña J; Department of Hematology-Oncology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Koch E; Department of Hematology-Oncology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Garrido M; Department of Hematology-Oncology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Pinto MP; Department of Hematology-Oncology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Sánchez C; Department of Hematology-Oncology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Curr Med Res Opin ; 36(7): 1195-1199, 2020 07.
Article en En | MEDLINE | ID: mdl-32351137
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Antineoplásicos Hormonales Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Curr Med Res Opin Año: 2020 Tipo del documento: Article País de afiliación: Chile
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Antineoplásicos Hormonales Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Curr Med Res Opin Año: 2020 Tipo del documento: Article País de afiliación: Chile